Owlet Inc Stock Price, News & Analysis

Owlet (NYSE: OWLT) announced a proposed underwritten public offering of its Class A common stock on October 21, 2025. The company said it will grant underwriters a 30-day option to buy up to 15% additional shares at the offering price less underwriting discounts and commissions. All shares are being offered by Owlet, with net proceeds intended to support continued commercialization, research and development, and general corporate purposes.

William Blair and TD Cowen are joint bookrunners and Craig-Hallum is co-manager. The offering is subject to market conditions and will be made by prospectus supplement filed under Owlet’s effective Form S-3 (File No. 333-281556). Prospective investors can obtain the preliminary prospectus supplement from the underwriters or the SEC website.

Owlet (NYSE: OWLT) received CDSCO approval to distribute Dream Sock in India and plans a broader launch of Dream Sock, Dream Sight and Dream Duo in early 2026. The company says its wearable Dream Sock monitors oxygen and pulse for infants 0–18 months (2.5–13.6 kg) and pairs with the Dream App and Base Station for real-time alerts. Owlet noted India’s large birth cohort (~23 million babies expected in 2025), >80% urban smartphone penetration, and that its products are already used by 2 million families in 30+ countries.

Owlet (NYSE: OWLT) announced that on September 30, 2025 its Compensation Committee approved an equity inducement award for Jordan Thompson, Vice President and Corporate Controller, in connection with his hiring. The award consists of 129,863 restricted stock units (Inducement RSUs). Vesting: 33.33% on May 15, 2026, then the remainder in equal quarterly installments through May 15, 2028, subject to continued employment. The Committee approved the award using the NYSE employment inducement exemption under Rule 303A.08, so shareholder approval was not required.

Owlet (NYSE: OWLT) has announced a proposed settlement of stockholder derivative litigation. The settlement, detailed in a Stipulation dated April 2, 2025, requires Owlet to implement corporate governance reforms and internal controls. The settlement hearing is scheduled for February 6, 2026, at the U.S. District Court for the Central District of California.

As part of the settlement, Plaintiffs' Counsel is requesting $675,000 in attorneys' fees and expenses, which Defendants have agreed not to oppose. Current Owlet stockholders as of April 2, 2025, have the right to object to the settlement by filing written objections at least 14 days before the settlement hearing.

Owlet (NYSE:OWLT) has launched its new Dream Sight™ HD video baby monitor and next-generation Dream Duo™ system. The Dream Sight, priced at $99.99, features 2K HD resolution, motion detection, two-way talk capabilities, and 256-bit encryption. It can be used standalone or integrated with the FDA-cleared Dream Sock.

The premium Dream Duo bundle, retailing at $379.99, combines Dream Sight with the medically-certified Dream Sock, which monitors baby's oxygen level, pulse rate, and sleep trends. Clinical data shows 96% of parents report reduced anxiety and 94% experience better sleep using Owlet products.

The products are available in the U.S., Canada, the UK, and Europe through major retailers including Amazon, Target, and Walmart.

Owlet (NYSE: OWLT) has announced the expansion of its medically-certified Dream Sock™ into South Africa, marking its presence across three continents including North America, Europe, and Africa. The Dream Sock, distributed as a Class C Medical Device with CE Marking, is designed for babies aged 0-18 months and monitors vital signs including pulse rate, oxygen level, and sleep patterns.

The device connects to the Owlet Dream App and Base Station, providing real-time health notifications to parents. The system includes Predictive Sleep Technology and can be paired with Owlet Cam® 2 for comprehensive monitoring. The product is NAPPI coded for medical aid reimbursement and available through major retailers in South Africa.

Owlet (NYSE: OWLT) has announced the expansion of its medically-certified Dream Sock™ to South Africa, marking its presence across three continents - North America, Europe, and Africa. The Dream Sock™, distributed as a Class C Medical Device with CE Marking, is designed for babies aged 0-18 months and monitors vital signs including pulse rate, oxygen level, and sleep patterns.

The device connects to the Owlet Dream App and Base Station, providing real-time health notifications to parents. The product features Predictive Sleep Technology and can be paired with Owlet Cam® 2 as part of the Dream Duo™ package. The Dream Sock is NAPPI coded, making it eligible for medical aid reimbursement when purchased through healthcare providers in South Africa.

Owlet (NYSE:OWLT), a smart infant monitoring technology company, has received Therapeutic Goods Administration (TGA) certification for its Dream Sock™ device in Australia and New Zealand. The Dream Sock is a wearable smart baby monitor designed for infants aged 0-18 months that tracks vital health indicators including pulse rate, oxygen level, and sleep patterns.

The certification paves the way for Owlet's expansion in these markets, with the product expected to launch later in 2025 through the company's website and retail partners like Baby Bunting. The device, which has already monitored over 2 million babies globally, provides real-time health data through the Owlet Dream App and Base Station.

Owlet (NYSE:OWLT) reported strong Q2 2025 financial results, with revenue reaching $26.1 million, up 25.9% year-over-year. The company achieved a gross margin of 51.3%, improving 180 basis points from Q2 2024. Despite posting a net loss of $37.6 million (including a $34.8 million non-cash warrant adjustment), Owlet delivered positive Adjusted EBITDA of $0.3 million.

The company announced a significant leadership change, with President Jonathan Harris succeeding founder Kurt Workman as CEO effective October 1, 2025. Workman will transition to Executive Chairman. Additionally, Owlet raised its full-year 2025 guidance, now expecting revenue between $97-100 million (24-28% growth) and projecting full-year adjusted EBITDA profitability.

Owlet's subscription service Owlet360 showed strong momentum, surpassing 66,000 paying subscribers with improvements in monthly recurring revenue, attach rate, and retention.